JP2024513003A5 - - Google Patents

Info

Publication number
JP2024513003A5
JP2024513003A5 JP2023559849A JP2023559849A JP2024513003A5 JP 2024513003 A5 JP2024513003 A5 JP 2024513003A5 JP 2023559849 A JP2023559849 A JP 2023559849A JP 2023559849 A JP2023559849 A JP 2023559849A JP 2024513003 A5 JP2024513003 A5 JP 2024513003A5
Authority
JP
Japan
Prior art keywords
csf1r
modified
nucleic acid
recombinant nucleic
acid molecule
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023559849A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024513003A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2022/023139 external-priority patent/WO2022212897A1/en
Publication of JP2024513003A publication Critical patent/JP2024513003A/ja
Publication of JP2024513003A5 publication Critical patent/JP2024513003A5/ja
Pending legal-status Critical Current

Links

JP2023559849A 2021-04-01 2022-04-01 Csf1rアンタゴニストに対する耐性を付与するための哺乳動物細胞の遺伝子改変 Pending JP2024513003A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US202163169578P 2021-04-01 2021-04-01
US63/169,578 2021-04-01
US202163236951P 2021-08-25 2021-08-25
US63/236,951 2021-08-25
PCT/US2022/023139 WO2022212897A1 (en) 2021-04-01 2022-04-01 Genetic modification of mammalian cells to confer resistance to csf1r antagonists

Publications (2)

Publication Number Publication Date
JP2024513003A JP2024513003A (ja) 2024-03-21
JP2024513003A5 true JP2024513003A5 (cg-RX-API-DMAC7.html) 2025-04-03

Family

ID=83456857

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023559849A Pending JP2024513003A (ja) 2021-04-01 2022-04-01 Csf1rアンタゴニストに対する耐性を付与するための哺乳動物細胞の遺伝子改変

Country Status (8)

Country Link
US (3) US20230248775A1 (cg-RX-API-DMAC7.html)
EP (1) EP4314003A4 (cg-RX-API-DMAC7.html)
JP (1) JP2024513003A (cg-RX-API-DMAC7.html)
AU (1) AU2022252407A1 (cg-RX-API-DMAC7.html)
CA (1) CA3215311A1 (cg-RX-API-DMAC7.html)
DE (4) DE202022003132U1 (cg-RX-API-DMAC7.html)
GB (1) GB2612467B (cg-RX-API-DMAC7.html)
WO (1) WO2022212897A1 (cg-RX-API-DMAC7.html)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US12612599B2 (en) 2018-09-10 2026-04-28 Savanna Biotherapeutics, Inc. Compositions and methods for microglia replacement therapy
DE202022003132U1 (de) * 2021-04-01 2025-02-17 The Regents Of The University Of California Genetische Modifikation von Säugerzellen zur Verleihung von Resistenz gegen CSF1R-Antagonisten

Family Cites Families (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1576139A4 (en) * 2002-11-26 2007-06-20 Cold Spring Harbor Lab INTERACTIVE PROTEINS AND ASSOCIATED METHODS OF DEP-1 RECEPTOR PROTEIN-TYROSINE PHOSPHATASE
US9044503B2 (en) 2004-08-27 2015-06-02 University Of Kentucky Research Foundation Amyloid peptide inactivating enzyme to treat alzheimer's disease peripherally
WO2006069203A2 (en) 2004-12-22 2006-06-29 California Institute Of Technology Methods for proteomic profiling using non-natural amino acids
WO2009089635A1 (en) 2008-01-16 2009-07-23 Neurodyn, Inc. Treating neurodegenerative diseases with progranulin (pgrn)
KR20100054711A (ko) 2008-11-14 2010-05-25 메디포스트(주) 간엽 줄기세포 또는 이의 배양액을 포함하는 신경질환의 예방 또는 치료용 조성물
EP2424976B1 (en) 2009-04-28 2013-07-31 Life & Brain GmbH Method for obtaining human microglial precursor cells from pluripotent stem cells
US8765117B2 (en) 2009-06-10 2014-07-01 The General Hospital Corporation Generation of vascularized human heart tissue and uses thereof
CA2818253A1 (en) 2010-11-16 2012-05-24 Denis G. Kay Method for increasing neprilysin expression and activity
CA2831609C (en) 2011-03-30 2019-06-11 Cellular Dynamics International, Inc. Priming of pluripotent stem cells for neural differentiation
EP3092305B1 (en) 2014-01-09 2023-08-02 Kyushu University, National University Corporation Method of producing microglial cells
US10081792B2 (en) 2014-12-31 2018-09-25 Wisconsin Alumni Research Foundation Derivation of human microglia from pluripotent stem cells
CA2972598C (en) 2014-12-31 2024-03-12 Wisconsin Alumni Research Foundation Human pluripotent stem cell-based models for predictive developmental neural toxicity
JP6774952B2 (ja) 2015-01-16 2020-10-28 エージェンシー フォー サイエンス, テクノロジー アンド リサーチ 多能性幹細胞のマクロファージへの分化
US10626372B1 (en) 2015-01-26 2020-04-21 Fate Therapeutics, Inc. Methods and compositions for inducing hematopoietic cell differentiation
WO2016210313A1 (en) 2015-06-24 2016-12-29 Whitehead Institute For Biomedical Research Culture medium for generating microglia from pluripotent stem cells and related methods
CA3016575A1 (en) 2016-03-03 2017-09-08 New York Stem Cell Foundation, Inc. Microglia derived from pluripotent stem cells and methods of making and using the same
WO2017223199A1 (en) 2016-06-22 2017-12-28 Xcell Biosciences, Inc. Methods for increasing cell culture transfection efficiency and cellular reprogramming
CN109963940A (zh) 2016-09-02 2019-07-02 宝生物工程株式会社 从多能干细胞获得小胶质细胞的方法
CA3038690A1 (en) 2016-10-05 2018-04-12 FUJIFILM Cellular Dynamics, Inc. Generating mature lineages from induced pluripotent stem cells with mecp2 disruption
CN110621774A (zh) 2016-10-14 2019-12-27 儿童医疗中心有限公司 用于治疗中枢神经系统疾病和病症的组合物和方法
WO2018160496A1 (en) 2017-02-28 2018-09-07 The Regents Of The University Of California Differentiation and use of human microglia-like cells from pluripotent stem cells and hematopoietic progenitors
WO2019118951A2 (en) 2017-12-15 2019-06-20 Duke University Compositions and methods of enhancing the homing and/or engraftment of hematopoietic cells in the central nervous system
US12171764B2 (en) * 2018-06-20 2024-12-24 Biora Therapeutics, Inc. Treatment of a disease of the gastrointestinal tract with a JAK or other kinase inhibitor
WO2020033791A1 (en) * 2018-08-09 2020-02-13 Verseau Therapeutics, Inc. Oligonucleotide compositions for targeting ccr2 and csf1r and uses thereof
US12612599B2 (en) * 2018-09-10 2026-04-28 Savanna Biotherapeutics, Inc. Compositions and methods for microglia replacement therapy
CN113166219A (zh) 2018-09-28 2021-07-23 纪念斯隆-凯特琳癌症中心 干细胞衍生的人小神经胶质细胞、制备方法及使用方法
US12419915B2 (en) 2019-03-13 2025-09-23 The Broad Institute, Inc. Microglial progenitors for regeneration of functional microglia in the central nervous system and therapeutics uses thereof
WO2020232512A1 (en) 2019-05-22 2020-11-26 The Council Of The Queensland Institute Of Medical Research Microglial cells and methods of use thereof
WO2020252477A1 (en) 2019-06-14 2020-12-17 FUJIFILM Cellular Dynamics, Inc. Methods for the production of multiple lineages from induced pluripotent stem cells using charged surfaces
EP4010361A4 (en) 2019-08-06 2023-08-09 Children's Medical Center Corporation METHODS AND COMPOSITIONS FOR RESTORING MICROGLIA
TWI799733B (zh) 2019-08-26 2023-04-21 臺北榮民總醫院 一種從體細胞製備誘導性多能幹細胞之方法
WO2021221879A1 (en) 2020-05-01 2021-11-04 Albert Einstein College Of Medicine Compositions and methods for using transplanted microglia as a vehicle for widespread delivery of cells and other biologic agents to the brain
US20240117431A1 (en) 2020-06-02 2024-04-11 The Regents Of The University Of California Stem-cell based biomarker discovery
GB202011871D0 (en) 2020-07-30 2020-09-16 Cambridge Entpr Ltd Composition and method
EP4204544A4 (en) 2020-08-25 2024-10-30 University Health Network COMPOSITIONS AND METHODS FOR GENERATING HUMAN YOLK SAC-TYPE HEMATOPOIETIC CELLS
DE202022003132U1 (de) 2021-04-01 2025-02-17 The Regents Of The University Of California Genetische Modifikation von Säugerzellen zur Verleihung von Resistenz gegen CSF1R-Antagonisten

Similar Documents

Publication Publication Date Title
Ubeda et al. Stress-induced binding of the transcription factor CHOP to a novel DNA control element
Kurschner et al. CIPP, a novel multivalent PDZ domain protein, selectively interacts with Kir4. 0 family members, NMDA receptor subunits, neurexins, and neuroligins
Meurs et al. Molecular cloning and characterization of the human double-stranded RNA-activated protein kinase induced by interferon
Inoue et al. IκBγ, a 70 kd protein identical to the C-terminal half of p110 NF-κB: a new member of the IκB family
Mogensen et al. The type I interferon receptor: structure, function, and evolution of a family business
Horvath et al. Interactions between STAT and non-STAT proteins in the interferon-stimulated gene factor 3 transcription complex
Shuai Interferon-activated signal transduction to the nucleus
Dingwall et al. A family of Ran binding proteins that includes nucleoporins.
US9746475B2 (en) Antibody and antibody mimetic for visualization and ablation of endogenous proteins
Posern et al. Development of highly selective SH3 binding peptides for Crk and CRKL which disrupt Crk-complexes with DOCK180, SoS and C3G
CN115850387B (zh) 超高亲和力的靶向pd-l1的小蛋白及药物组合物
EP3481858A1 (en) Modified ligand-gated ion channels and methods of use
US6338949B1 (en) Nucleic acids encoding receptor recognition factor stat4 and methods of use thereof
JP2653653B2 (ja) インターフエロン誘起遺伝子及び酵素
Qin et al. Leader RNA regulates snakehead vesiculovirus replication via interacting with viral nucleoprotein
Hara et al. A small fragmented P protein of respiratory syncytial virus inhibits virus infection by targeting P protein
CN107034201B (zh) 表观修饰酶setd2的抗病毒作用及其应用
Dunbar et al. Two-hybrid cloning of a gene encoding TNF receptor-associated protein 2, a protein that interacts with the intracellular domain of the type 1 TNF receptor: identity with subunit 2 of the 26S protease
EP0720652A1 (en) Receptor recognition factors, protein sequences and methods of use thereof
CA2132317A1 (en) Ifn receptors recognition factors, protein sequences and methods of use thereof
Graw et al. Genomic sequences of murine γB-and γC-crystallm-encoding genes: promoter analysis and complete evolutionary pattern of mouse, rat and human γ-crystallins
US7060682B2 (en) Receptor recognition factors, protein sequences and methods of use thereof
Rodriguez et al. NAP‐2 is part of multi‐protein complexes in Hela cells
US6403299B1 (en) DEAH-box proteins
CN121347805B (zh) 靶向sting-pdzd8相互作用蛋白的药物筛选系统及其应用